206258-97-1 Usage
General Description
8-Bromo-4-chloroquinoline-3-carboxylic acid ethyl ester is a chemical compound that belongs to the quinoline family. It is an ethyl ester derivative of 8-bromo-4-chloroquinoline-3-carboxylic acid and is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. 8-Bromo-4-chloroquinoline-3-carboxylic acid ethyl ester has potential biological activities and is primarily utilized in medicinal chemistry research. Its unique structure and properties make it a valuable building block in the development of new drug candidates. Additionally, it may also have applications in the development of new pesticides and herbicides for agricultural use.
Check Digit Verification of cas no
The CAS Registry Mumber 206258-97-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,6,2,5 and 8 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 206258-97:
(8*2)+(7*0)+(6*6)+(5*2)+(4*5)+(3*8)+(2*9)+(1*7)=131
131 % 10 = 1
So 206258-97-1 is a valid CAS Registry Number.
InChI:InChI=1/C12H9BrClNO2/c1-2-17-12(16)8-6-15-11-7(10(8)14)4-3-5-9(11)13/h3-6H,2H2,1H3
206258-97-1Relevant articles and documents
BICYCLIC DERIVATIVES FOR TREATING ENDOPARASITES
-
, (2020/12/29)
The present invention provides compounds of formula (I): which are useful in the control of endoparasites, for example heartworms, in warm-blooded animals.
PROCESS FOR PREPARING ANTIHELMINTIC 4-AMINO-QUINOLINE-3-CARBOXAMIDE DERIVATIVES
-
, (2019/07/19)
The present invention relates to a new process for preparing quinoline compounds of the general formula (II): in which Q, A, R4, R3 and R3',are as defined herein, as well as to the intermediate compounds of said new process.
BICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS
-
, (2013/08/28)
The present disclosure is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, as mPGES-1 inhibitors. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme and are therefore useful in the treatment of pain and/or inflammation from a variety of diseases or conditions, such as asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative diseases.
